Literature DB >> 16682179

Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia.

Ivana I Vranic1, Mihailo Matic, Jovan Perunicic, Tijana Simic, Ljiljana Soskic, Natasa Milic.   

Abstract

PSVT attack of >20min and frequency >160 is well-recognized model of myocardial dysfunction. We measured 6-keto-PGF1alpha and TXB(2) before and after adenosine administration to assess its cardioprotective potential. A total of 64 patients were randomly assigned as having acute episode of PSVT to adenosine or verapamil group. A bolus of 6mg of adenosine up to the maximum dose of 12 or 5mg of verapamil up to the maximum dose of 10mg were given, until the sinus rhythm was restored. The levels of PGI(2), TXA(2) and TAS were measured in three different time intervals. In adenosine group all parameters were normalized after 20min of conversion to sinus rhythm. The ratio of PGI(2)/TXA(2) increased after 5min of conversion to SR (P<0.01). Also, the ratio of TXA(2)/TAS was decreased for ADO (P<0.01). This is the first study to demonstrate that adenosine exerts cardioprotective effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682179     DOI: 10.1016/j.plefa.2006.03.005

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  1 in total

Review 1.  Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

Authors:  Samer Alabed; Ammar Sabouni; Rui Providencia; Edmond Atallah; Mohammed Qintar; Timothy Ja Chico
Journal:  Cochrane Database Syst Rev       Date:  2017-10-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.